Exact Mass: 396.1699

Exact Mass Matches: 396.1699

Found 14 metabolites which its exact mass value is equals to given mass value 396.1699, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

2-(2-Amino-1H-benzo[d]imidazol-1-yl)-N-benzyl-8-methoxyquinazolin-4-amine

2-(2-Amino-1H-benzimidazol-1-yl)-8-methoxy-N-(phenylmethyl)-4-quinazolinamine

C23H20N6O (396.1699)


   

Mocetinostat

N-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide

C23H20N6O (396.1699)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

   
   

MLS002154212-01!Canrenoic acid potassium salt2181-04-6

MLS002154212-01!Canrenoic acid potassium salt2181-04-6

C22H29KO4 (396.1703)


   

10,11-epoxy-chlorovulone I

methyl 9-oxo-10R-chloro-10,11S-epoxy-12S-hydroxy-5Z,7E13Z-prostatrienoate-cyclo[8,12]

C21H29ClO5 (396.1703)


   

10,11-epoxy-chlorovulone I

methyl 9-oxo-10R-chloro-10,11S-epoxy-12S-hydroxy-5Z,7E13Z-prostatrienoate-cyclo[8,12]

C21H29O5Cl (396.1703)


   

LGK 974

2-(2,3-Dimethyl-[2,4-bipyridin]-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide

C23H20N6O (396.1699)


D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   

Mocetinostat

Mocetinostat(MGCD0103)

C23H20N6O (396.1699)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

   

Potassium canrenoate

Potassium canrenoate

C22H29KO4 (396.1703)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents > C03DA - Aldosterone antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D045283 - Natriuretic Agents > D004232 - Diuretics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-(2-Amino-1H-benzo[d]imidazol-1-yl)-N-benzyl-8-methoxyquinazolin-4-amine

2-(2-Amino-1H-benzo[d]imidazol-1-yl)-N-benzyl-8-methoxyquinazolin-4-amine

C23H20N6O (396.1699)


   

Epoxy-chlorovulone I

Epoxy-chlorovulone I

C21H29ClO5 (396.1703)


   

methyl 7-[1-chloro-4-hydroxy-4-(oct-2-en-1-yl)-2-oxo-6-oxabicyclo[3.1.0]hexan-3-ylidene]hept-5-enoate

methyl 7-[1-chloro-4-hydroxy-4-(oct-2-en-1-yl)-2-oxo-6-oxabicyclo[3.1.0]hexan-3-ylidene]hept-5-enoate

C21H29ClO5 (396.1703)


   

(11r,12r)-10-imino-12-(1h-indole-3-carbonyl)-n,n-dimethyl-8,13,15-triazatetracyclo[7.6.0.0²,⁷.0¹¹,¹⁵]pentadeca-1(9),2,4,6,13-pentaen-14-amine

(11r,12r)-10-imino-12-(1h-indole-3-carbonyl)-n,n-dimethyl-8,13,15-triazatetracyclo[7.6.0.0²,⁷.0¹¹,¹⁵]pentadeca-1(9),2,4,6,13-pentaen-14-amine

C23H20N6O (396.1699)


   

10-imino-12-(1h-indole-3-carbonyl)-n,n-dimethyl-8,13,15-triazatetracyclo[7.6.0.0²,⁷.0¹¹,¹⁵]pentadeca-1(9),2,4,6,13-pentaen-14-amine

10-imino-12-(1h-indole-3-carbonyl)-n,n-dimethyl-8,13,15-triazatetracyclo[7.6.0.0²,⁷.0¹¹,¹⁵]pentadeca-1(9),2,4,6,13-pentaen-14-amine

C23H20N6O (396.1699)